Table 3.
Median and interquartile range of selected mediators.
| RR-MS |
p-Valuea | ||
|---|---|---|---|
| IFN-β treatment (n = 30) | Untreated (n = 30) | ||
| APRIL (pg/mL) | 68.0 (44.5–100.5) | 50.7 (39.4–78.4) | 0.537 |
| BAFF (pg/mL) | 415.6 (230.7–792.3) | 400.4 (221.6–504.9) | 0.622 |
| BAFFR (pg/mL) | 27.9 (23.3–30.4) | 29.8 (25.0–36.3) | 0.429 |
ap-Value relative to Mann–Whitney U test between groups.
IFN, interferon; APRIL, a proliferation-inducing ligand; BAFF, B-cell activating factor; BAFFR, BAFF receptor; RR-MS, relapsing–remitting multiple sclerosis.